22157.jpg
Biopharmaceutical Industry Emerging Technologies, Trends and Macroeconomic Factors to Dominate in 2024: Cell and Gene Therapies will be the Key Focus in 2024
January 17, 2024 11:38 ET | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition" report has been added to ResearchAndMarkets.com's offering.While the fight against COVID-19 is...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
January 09, 2024 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...
Global Microbiome Market
Microbiome Market Trends Report 2023: Emerging Therapeutics and Omics-based Research Spotlighting Global Progress
January 09, 2024 06:14 ET | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. New research findings delve into the swiftly expanding...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conference
January 08, 2024 16:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
22157.jpg
Bioprocess Validation Market Analysis 2024-2033: Focused Insights on Test Types, End Users, and Regional Growth Forecasts through 2033
January 08, 2024 05:03 ET | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033"...
Global Natural Killer Cells Therapeutics Market
Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028
January 03, 2024 11:33 ET | Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Logo.png
Biopharmaceuticals Global Market is Expected to Surpass 700 Billion Mark by 2028, Assesses DelveInsight
January 02, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Biopharmaceuticals Global Market is Expected to Surpass 700 Billion Mark by 2028, Assesses DelveInsight The demand for biopharmaceuticals is...
22157.jpg
Global Microcarriers Market Analysis: A Comprehensive Forecast of Biopharmaceutical Production, End User Segments and Market Growth 2024-2033
December 28, 2023 04:58 ET | Research and Markets
Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Microcarriers Market: Focus on Biopharmaceutical Production, End User, Products, and Over 12 Countries' Data - Analysis and Forecast, 2024-2033"...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
December 20, 2023 07:00 ET | Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
European Wound Biologics Market
Europe Wound Biologics Market Insights Report 2023-2028: Specialty Wound Clinics Accounted for the Highest Share of 54.33% in 2022
December 07, 2023 05:18 ET | Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "Europe Wound Biologics Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. European wound biologics...